Management Team


Rick Bunker


Rick is a co-founder and the CEO of Prescription Advisory. In this role, he is responsible for capital formation and corporate development.

Rick brings over 25 years of executive experience to Prescription Advisory, specializing in general management and software development team leadership, especially in venture and PE backed companies. He has held executive level technology positions for three publicly traded companies – SEIC, ICGE, GSIC (now a division of eBay) – and was CEO of Reality Online, a Reuter’s subsidiary that was a pioneer in internet delivery of consumer financial services.

In addition to his technology leadership, Rick has worked on over 100 M&A transactions. He is a veteran of the United States Army Security Agency, a graduate of the Defense Language Institute and attended Boston University — studying Russian Language and Literature. In his personal time, Rick is active in local politics and is Vice President of the Jenkintown Borough Council and serves on the Jenkintown Human Relations Committee.


Eric Corkhill

President/Chief Revenue Officer

Eric joined full time in August 2016. Over the past 30 years, Eric has aggressively grown startup companies and accelerated growth of existing organizations. Eric has expertise in both the payor and provider healthcare sectors with proven ability to create markets for new products or to expand market penetration and client satisfaction of established products. He has successfully established new sales processes utilizing best practices and performance driven metrics throughout his career. He has managed both direct sales and complex sales channels and developed multi-tiered marketing strategies while enhancing client retention and revenue contribution. For five years prior to joining Prescription Advisory, Eric was the Chief Revenue Officer at Notifi Health LLC. Prior to Notifi Health, Eric was Vice President of Sales and Marketing for HIT Application Solutions (5 years), a company aimed at allowing physicians to provide better care via technology. Eric is a graduate of the University of Virginia with a Bachelor of Arts in Art History, Marketing and Biology-1980.


David Stengle

Chief Marketing Officer

David brings over 25 years of executive experience to Prescription Advisory, specializing in enterprise software and transactional systems. Prior to Prescription Advisory, David spent a decade at BlackArrow, where he ran business development including channel sales and strategic partnerships. He developed strategic relations resulting in investment leads for multiple rounds of funding.

Prior to BlackArrow, David worked mostly with private equity companies including serving as CEO of Starnet, another ad tech company. He started as a software developer.

David’s enthusiasm for startups extends beyond Prescription Advisory. He is the Director of Startup Grind Princeton and a mentor for the Princeton University eLab.


Vincent Mendola

Chief Financial Officer

Vince earned his CPA (NJ) in 1989 and MBA in finance from Drexel University in 1994. He brings experience in the areas of business turnaround, top and bottom line growth, acquisitions and financing (bank/SBA) for businesses ranging from $10 to $75 million in sales.

Prior experiences include CFO – Rhoads Industries (7 years-industrial services & metal fabrication), CFO – Advertising Specialty Institute (3 years -technology and publishing), CFO/COO – Reality On-Line (a Reuters company-5 years- information and technology), CFO/COO – Thomas Cook USA (10 years – financial services). Vince was also the controller for Medical Resources, Inc., a public company involved in the roll-up of hundreds of radiology practices between 1994 and 1998.

Follow Prescription Advisory

Thirteen multi-state PDMP projects were sponsored in 2012-13. While providers indicated that PDMPs gave them more confidence for prescribing pain medication, the study concluded that the easier the data is to obtain, the more they will be used, and the safer the practice can be.


Substance Abuse & Mental Health Services AdministrationOffice of the National Coordinator for Health IT, & MITRE Corp

Prescription drug monitoring programs (PDMPs) are now active in most states to assist clinicians in identifying potential controlled drug misuse, diversion, or excessive prescribing. Little is still known about the ways in which they are incorporated into workflow and clinical decision making, what barriers continue to exist, and how clinicians are sharing PDMP results with their patients.

Qualitative data were collected through online focus groups and telephone interviews.

Clinicians from pain management, emergency and family medicine, psychiatry/behavioral health, rehabilitation medicine, internal medicine and dentistry participated.

Thirty-five clinicians from nine states participated.

We conducted two online focus groups and seven telephone interviews. A multidisciplinary team then used a grounded theory approach coupled with an immersion–crystallization strategy for identifying key themes in the resulting transcripts.

Some participants, mainly from pain clinics, reported checking the PDMP with every patient, every time. Others checked only for new patients, for new opioid prescriptions, or for patients for whom they suspected abuse. Participants described varied approaches to sharing PDMP information with patients, including openly discussing potential addiction or safety concerns, avoiding discussion altogether, and approaching discussion confrontationally. Participants described patient anger or denial as a common response and noted the role of patient satisfaction surveys as an influence on prescribing.

Routines for accessing PDMP data and how clinicians respond to it vary widely. As PDMP use becomes more widespread, it will be important to understand what approaches are most effective for identifying and addressing unsafe medication use.

Pain Medicine, Volume 15, Issue 7, July 2014 
Share This
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.